The iCHOR iDVT venous reperfusion system has demonstrated consistent safety, efficacy, and procedural performance across a diverse spectrum of clinical presentations in limited market release...
Author: iCHOR
iCHOR Funding Early Commercialization
iCHOR Vascular. Clearing the path As iCHOR Vascular finishes the limited market release (LMR) data and evaluation, we are transitioning into a planned early commercial...
The Silicon Review Names iCHOR Among Fastest Growing Companies of 2026
The Silicon Review has identified iCHOR Vascular as on of the fastest growing innovative companies on its radar to watch in 2026. The article summarizes...
